260 related articles for article (PubMed ID: 29745433)
1. lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.
Du Y; Wang L; Chen S; Liu Y; Zhao Y
Mol Carcinog; 2018 Sep; 57(9):1191-1200. PubMed ID: 29745433
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway.
Sun KX; Wu DD; Chen S; Zhao Y; Zong ZH
Apoptosis; 2017 Dec; 22(12):1543-1552. PubMed ID: 29094270
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A protein.
Chen S; Wang LL; Sun KX; Liu Y; Guan X; Zong ZH; Zhao Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3013-3021. PubMed ID: 29920344
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
5. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Wang LL; Sun KX; Wu DD; Xiu YL; Chen X; Chen S; Zong ZH; Sang XB; Liu Y; Zhao Y
J Cell Mol Med; 2017 Nov; 21(11):3055-3065. PubMed ID: 28598010
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b.
Xie P; Cao H; Li Y; Wang J; Cui Z
Cancer Biomark; 2017 Dec; 21(1):123-133. PubMed ID: 29036788
[TBL] [Abstract][Full Text] [Related]
7. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA DLEU1 contributes to the development of endometrial cancer by sponging miR-490 to regulate SP1 expression.
Shao W; Li Y; Chen F; Jia H; Jia J; Fu Y
Pharmazie; 2018 Jul; 73(7):379-385. PubMed ID: 30001771
[TBL] [Abstract][Full Text] [Related]
9. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma.
Li Q; Shen F; Zhao L
Biomed Pharmacother; 2018 Nov; 107():918-928. PubMed ID: 30257404
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Serum lncRNA DLEU1 Predicts Progression of Premalignant Endometrial Lesion and Unfavorable Clinical Outcome of Endometrial Cancer.
Shan L; Zhao T; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820965589. PubMed ID: 33327893
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway.
Lei X; Guo J; Wang Y; Cui J; Feng B; Su Y; Zhao H; Yang W; Hu Y
J BUON; 2019; 24(4):1555-1561. PubMed ID: 31646808
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway.
Yue G; Chen C; Bai L; Wang G; Huang Y; Wang Y; Cui H; Xiao Y
Mol Med Rep; 2019 Nov; 20(5):4551-4557. PubMed ID: 31702026
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA H19 promotes invasion and autophagy via the PI3K/AKT/mTOR pathways in trophoblast cells.
Xu J; Xia Y; Zhang H; Guo H; Feng K; Zhang C
Biomed Pharmacother; 2018 May; 101():691-697. PubMed ID: 29522949
[TBL] [Abstract][Full Text] [Related]
15. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
Zhang S; Wang M; Li Q; Zhu P
Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
[TBL] [Abstract][Full Text] [Related]
16. SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway.
Wu W; Chen X; Liu X; Bao HJ; Li QH; Xian JY; Lu BF; Zhao Y; Chen S
Mol Carcinog; 2023 Apr; 62(4):413-426. PubMed ID: 36562475
[TBL] [Abstract][Full Text] [Related]
17. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
18. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
[TBL] [Abstract][Full Text] [Related]
20. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
